Neutropenia Management and Diagnosis
Classification and Diagnosis
- The American College of Physicians recommends distinguishing between acute versus chronic patterns of neutropenia, then categorizing by mechanism: drug-induced, autoimmune, infectious, congenital, or idiopathic causes 1
- Severe neutropenia is defined as an absolute neutrophil count (ANC) <0.5 × 10^9/L, and profound neutropenia is defined as an ANC <0.1 × 10^9/L, according to the Infectious Diseases Society of America 3, 4, 5
- The differential diagnosis of recurrent neutropenia in adults should include consideration of benign ethnic neutropenia, which is common in individuals of African, Middle Eastern, or West Indian descent 4
Risk Stratification and Management
- High-risk features requiring immediate intervention include an ANC <0.1 × 10^9/L, anticipated prolonged neutropenia, a Multinational Association for Supportive Care in Cancer (MASCC) score <21, and presence of fever, as recommended by the National Comprehensive Cancer Network 3, 4, 7
- The Infectious Diseases Society of America recommends immediate hospitalization and empiric broad-spectrum antibiotics for febrile neutropenia, with a regimen including vancomycin and an antipseudomonal agent 6, 8
- Antimicrobial prophylaxis is recommended for high-risk patients, including antiviral, anti-pneumocystis, and antifungal prophylaxis, according to the European Society for Medical Oncology 9, 5, 6
- G-CSF (filgrastim) therapy is recommended for chronic severe neutropenia without fever, with a starting dose of 5-6 mcg/kg subcutaneously, and titration based on ANC response, as recommended by the American Society of Hematology 9, 5
Diagnostic Evaluation
- A bone marrow examination is indicated when the diagnosis remains unclear after initial workup, or when there is concern for myelodysplastic syndrome or leukemia, as recommended by the American Society of Clinical Oncology 6
- Autoimmune workup, including ANA, anti-dsDNA, RF, and anti-CCP antibodies, is recommended for patients with suspected autoimmune neutropenia, according to the American College of Rheumatology 6
- Infectious evaluation, including HIV, hepatitis B/C testing, and consideration of chronic viral infections, is recommended for patients with suspected infectious neutropenia, as recommended by the Centers for Disease Control and Prevention 1, 6